IP Library Granted Patent US 10,537,453
Granted Patent B2
US 10,537,453 · App. 15/335,256 · Granted Jan 21, 2020

Intragastric device with expandable portions

Inventors: Mark C. Brister (San Diego, CA); Betty Wong (San Diego, CA); Neil R. Drake (San Diego, CA); Sheldon Nelson (Vista, CA); Daniel J. Proctor (Carlsbad, CA); Kate Sapp (Encinitas, CA); Eleanor McCarthy (Oceanside, CA)
Assignee: Obalon Therapeutics, Inc.
A61F5/003A61F5/0036A61M25/10185
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,537,453
App. No.
15/335,256
Granted
Jan 21, 2020
Kind
B2
Abstract

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Claims (24)

1. An intragastric balloon configured to reside in an in vivo gastric environment for at least 30 days, comprising:

a polymeric wall configured to have, under conditions of an in vivo gastric environment, a permeability to CO 2 of more than 10 cc/m 2 /day, such that a rate and an amount of diffusion of CO 2 from the in vivo gastric environment into a lumen of the intragastric balloon through the polymeric wall is controlled, at least in part, by a concentration of an inert gas in an initial fill gas, wherein the polymeric wall is formed of a flexible material, wherein the flexible material includes one or more non-expandable sections and one or more expandable sections, wherein the expandable sections are configured to stretch from 10% to 400% in response to an increased volume of a fluid inside the lumen of the intragastric balloon; and

a valve system configured for introducing the initial fill gas into the lumen of the intragastric balloon in the in vivo gastric environment.

2. The intragastric balloon of claim 1 , wherein the polymeric wall comprises a three layer CO 2 barrier material consisting of nylon/polyvinylidene chloride/polyethylene.

3. The intragastric balloon of claim 1 , wherein the polymeric wall comprises a two layer CO 2 barrier material consisting of nylon/polyethylene material and no additional CO 2 barrier material.

4. The intragastric balloon of claim 1 , wherein the initial fill gas consists essentially of SF 6 and N 2 .

5. The intragastric balloon of claim 1 , wherein the initial fill gas consists essentially of SF 6 .

6. The intragastric balloon of claim 1 , wherein each of the one or more expandable sections is a band wrapped around a circumference of the intragastric balloon.

7. The intragastric balloon of claim 6 , wherein the band has one or more curved or angled sections.

8. The intragastric balloon of claim 1 , wherein the one or more expandable sections comprises multiple bands of expandable material.

9. The intragastric balloon of claim 1 , wherein each of the one or more nonexpandable sections comprises a non-expandable band that wraps around a circumference of the intragastric balloon.

10. The intragastric balloon of claim 1 , comprising a plurality of expandable panels.

11. The intragastric balloon of claim 10 , wherein the expandable panels are each the same size.

12. The intragastric balloon of claim 10 , comprising a plurality of nonexpandable panels.

13. The intragastric balloon of claim 12 , wherein the nonexpandable panels comprise a mesh.

14. The intragastric balloon of claim 12 , wherein there are an equal number of expandable panels and nonexpandable panels.

15. The intragastric balloon of claim 1 , comprising one or more expandable protrusions configured to protrude from a surface of the intragastric balloon.

16. The intragastric balloon of claim 1 , wherein the polymeric wall comprises a plurality of layers, wherein one or more sections of the layers are expandable.

17. The intragastric balloon of claim 1 , wherein the polymeric wall comprises 10% or less expandable material.

18. The intragastric balloon of claim 1 , in a compacted state and inside of a swallowable-sized container adapted to transcend an esophagus which has a diameter of approximately 2.5 cm.

19. The intragastric balloon of claim 1 , wherein the one or more non-expandable sections are patch segments.

20. A method for inflating an intragastric balloon, comprising:

introducing, in an in vivo intragastric environment, an initial fill gas comprising an inert gas into a lumen of an intragastric balloon according to claim 1 ; and

exposing the balloon to the in vivo intragastric environment for at least 30 days, wherein a rate and an amount of diffusion of CO 2 from the in vivo gastric environment into the lumen of the balloon through the polymeric wall is controlled, at least in part, by a concentration of an inert gas in the initial fill gas.

Assignments (3)
SECURITY INTEREST Recorded Oct 24, 2024
From: RESHAPE LIFESCIENCES INC.
To: ASCENT PARTNERS FUND LLC
Reel/Frame 070166/0882 →
CHANGE OF NAME Recorded Oct 6, 2021
From: OBALON THERAPEUTICS, INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 057726/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2016
From: BRISTER, MARK C.; WONG, BETTY; DRAKE, NEIL R.; NELSON, SHELDON; PROCTOR, DANIEL J.; SAPP, KATE; MCCARTHY, ELEANOR
To: OBALON THERAPEUTICS, INC.
Reel/Frame 040257/0983 →
Continuity (2)
Provisional Application 62268389 · Dec 16, 2015
Related Publication 20170172778A1 · Jun 22, 2017
Cited By (4)
US 12,350,179 US 12,440,358 US 12,465,364 US 12,514,464